INTRODUCTION
Psoriasis vulgaris (PsV) is a common chronic inflammatory skin disease that is characterized by cutaneous inflammation and keratinocyte hyperproliferation, and it is often accompanied by severe complications such as psoriatic arthritis (PsA) 1 . It is believed to result from pathological immune activation in genetically prone individuals. Substantial evidence supports a central role for T helper (TH) cells, such are TH1 and TH17 cells, in the pathogenesis of PsV 1 . A variety of cytokines have also been implicated, including the proinflammatory cytokine tumor necrosis factor alpha (TNF-α), the TH1-axis cytokines, interleukin (IL)-12 and interferon gamma (IFN-γ), and the TH17-axis cytokines IL-23 and IL-17 1 .
The importance of single nucleotide polymorphisms (SNPs) that affect cytokine production is well established and has been extensively studied, since SNPs may contribute to the susceptibility, severity, and clinical outcome of various Although all three functional SNPs in the genes encoding TNF-α, the p40 subunit of IL-12/23, and IFN-γ were associated with PsV and/or PsA in several studies 4, 9, 10 , there have also been a considerable number of studies that failed to replicate these results [11] [12] [13] [14] . Obviously, the influence of various genetic variants on PsV risk may be very complex due to the existence of stratification factors, such as ethnic variance and subtype of the disease. As there is a lack of comprehensive studies in the Serbian population, our aim was to analyze the association between these three functional SNPs and PsV in Serbian patients. 
MATERIALS AND METHODS

Patients
DNA extraction
Genomic DNA was isolated from peripheral blood that had been sampled in tubes containing ethylenediaminetetraacetic acid, using the GeneJET Whole Blood Genomic DNA Purification Mini Kit (Fermentas Thermo Fisher Scientific Inc., Vilnius, Lithuania).
SNP detection
Detection and analysis of the TNF −308 G/A (rs1800629) and IL12B ＋1188 A/C (rs3212227) polymorphisms were performed using real-time PCR with commercial TaqMan probes (Applied Biosystems Inc., Foster City, CA, USA) and Maxima Probe qPCR Master Mix (Fermentas Thermo Fisher Scientific Inc.), and the cycling conditions recommended by the manufacturer of the oligonucleotide mix. The IFNG ＋874 T/A (rs2430561) polymorphism was determined as previously described 16 .
Statistical analysis
Comparisons between genotype and allele frequencies in different populations were performed using Pearson's chi-square test, Fisher's exact test, or the Kruskal-Wallis test, followed by the Mann-Whitney U test, as appropriate. All genotype frequencies were in Hardy-Weinberg equilibrium.
RESULTS
The results of genotyping analysis for patients with PsV and healthy controls are presented in Table 2 . The genotype distribution of each of the three cytokine genes examined was similar in patients with PsV and the control population (Table 3 ). In addition, there were no significant dif- ferences between patients with either early onset (type 1) or late onset (type 2) PsV and the control subjects (Table  3) . When controls were compared with only those patients with PsV who also had PsA, a borderline significance was observed for the rs3212227 AC genotype (conferring protection) and AA genotype (conferring risk) of the IL12B gene SNP (p=0.049 and p=0.062, respectively), while genotypes for other gene SNPs did not differ between the groups (Table 3) . Furthermore, TNF, IL12B, and IFNG allele carriage analysis did not reveal any significant differences between controls and patients with PsV or PsA, or between the two types of PsV (data not shown). However, a decreased frequency of TNF G allele carriers among patients with a low PASI score reinforces the possible risk effect associated with this allele or, alternatively, indicates a protective role of the other allele (A) in PsV ( Table 4) . None of the TNF, IL12B, or IFNG allele combinations was significantly different in patients compared to control subjects (data not shown).
DISCUSSION
In this study, we investigated the association of PsV in Serbian patients with polymorphisms in the genes encoding TNF-α, the p40 subunit of IL-12/23, and IFN-γ, which had previously been reported to affect gene expression and to have possible roles in the disease's development and severity. The results of our investigation did not identify any Values are presented as number (%). Percentages refer to the portion of patients within a stratum, according to PASI score. PsV: psoriasis vulgaris, PASI: psoriasis activity and severity index. *p=0.022, † p=0.032, compared to low PASI group.
significant difference in allele frequencies or genotype distribution between our patients and healthy individuals. The important role of TNF-α in the pathogenesis of PsV is well established. However, the influences of SNPs located in the TNF promoter region, such as rs1800629, on altered PsV and PsA risk are less clear. Published studies show conflicting results, with some authors reporting association of this SNP with disease susceptibility 4 and others failing to find any association 11, 14 , suggesting that this TNF polymorphism may have diverse effects in a population made up of various ethnicities 4 . Thus, our result could reflect ethnic specificity in the Serbian population, although another study with more patients is needed in order to confirm this. In addition, the most recent meta-analysis revealed a significant protective effect of the TNF −308 A allele (genotypes AA and AG) in PsV 4 . This is in line with our finding of an association of the G allele with more severe disease, although the number of patients with low PASI score was small in our study. Data obtained for IL12B genotypes and alleles did not differ in our cohort of patients in comparison with disease-free individuals. This is in contrast with several studies from Europe, Asia, and America that demonstrated the protective effect of the rs3212227 C allele in PsV/PsA 10 . Such a discrepancy was probably due to a limited sample size in our study. Indeed, the frequency of the risk-conferring AA genotype in our study was clearly higher among PsV patients than the controls (0.74 vs. 0.67), but the difference did not reach statistical significance. Likewise, associations with the AC and AA genotypes were at the limits of significance when patients with PsA were compared with healthy individuals. Assuming the observed genotype frequencies, a total of more than 570 patients with PsV should have been included in our study in order to reach a power of 80% at a probability of p=0.05, which is beyond the number we could gather in our hospital.
Interestingly, similar genotype distributions and a lack of significant difference were observed in a recently published study of Spanish patients with PsV 12 .
In contrast to TNF and IL12B SNPs, studies analyzing the effects of the rs2430561 IFNG polymorphism on PsV development and severity are scarce, yet our results support previous evidence that this SNP does not directly influence susceptibility to PsV 11 . Lack of association of this IFNG polymorphism was also found in a comprehensive GWAS that looked for correlation between 438,670 SNPs in 1,539 PsV cases and 1,400 controls 13 . The only exception among these reports was a study by Baran et al. 9 that demonstrated, albeit in a limited number of individuals, the predominance of the TA heterozygote in a healthy group of individuals compared to patients with PsV.
The main caveat of our study is the relatively small sample size. Therefore, some associations could have been missed due to an insufficient number of patients and controls, as was probably the case for the IL12B ＋1188 A/C SNP. Consequently, our results are in apparent contrast to those from several previously published studies that demonstrated association between some of the SNPs and PsV. We believe that the observed differences are primarily due to the low number of patients in our study, since the odds ratios and confidence intervals obtained in our cohort are comparable to those from most other studies 4, 10, 12 . On the other hand, ethnic specificity of the Serbian population with regard to some of analyzed SNPs cannot be excluded. Despite these limitations, our study is relevant because it is the first to analyze the association of gene polymorphisms with PsV development and severity in the Serbian population. It is also one of the rare studies that evaluate the relevance of the IFNG ＋874 T/A polymorphism in patients with PsV. Therefore, the results of this study will expand genetic knowledge regarding the role of three important functional polymorphisms in PsV, which may prove valuable for future meta-analyses and, ultimately, therapy.
